(Total Views: 446)
Posted On: 11/04/2020 12:40:48 PM
Post# of 98
$ATNM News Article - 100% Remission Rate Reported in Third Dose Cohort of Actimab-A CLAG-M Phase 1 Combination Trial in Patients with Relapsed or Refractory AML https://marketwirenews.com/news-releases/100-...88420.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
